stockrowBioMarin Pharmaceutical Inc. (BMRN) vs Twist Bioscience Corporation (TWST)
- BioMarin Pharmaceutical Inc. BMRN 57.48 −1.76%
- Twist Bioscience Corporation TWST 129.86 −15.00%
BioMarin Pharmaceutical Inc. and Twist Bioscience Corporation are both Biotechnology companies. BioMarin Pharmaceutical Inc. is the larger, with a market value of $11.3B against $10.1B — 1.1× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; BioMarin Pharmaceutical Inc. trades at 154×. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 11.2%. BioMarin Pharmaceutical Inc. has the higher net margin (2.14% vs −31.7%) and the higher return on invested capital (0.97% vs −30.8%). Across the 19 metrics below, BioMarin Pharmaceutical Inc. leads on 13 and Twist Bioscience Corporation on 6.
Valuation
Profitability
| Metric | BMRN | TWST | Biotechnology median |
|---|---|---|---|
| Gross margin | 76.12% | 51.97% | 68.94% |
| Operating margin | 4.38% | (33.58%) | 0.00% |
| Net margin | 2.14% | (31.66%) | 0.00% |
| Free cash flow margin | 21.28% | (22.15%) | 0.00% |
| Return on equity | 1.18% | (29.59%) | (54.09%) |
| Return on assets | 0.76% | (20.78%) | (46.84%) |
| Return on invested capital | 0.97% | (30.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack